Innate Pharma Files 6-K Report
Ticker: IPHYF · Form: 6-K · Filed: May 15, 2025 · CIK: 1598599
| Field | Detail |
|---|---|
| Company | Innate Pharma SA (IPHYF) |
| Form Type | 6-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, regulatory-update
TL;DR
Innate Pharma dropped a 6-K filing on 5/15/25, likely with news.
AI Summary
Innate Pharma SA filed a Form 6-K on May 15, 2025, reporting a press release dated the same day. The filing does not contain specific financial figures or operational updates but serves as a notification to the SEC.
Why It Matters
This filing indicates Innate Pharma is providing an update or making an announcement to the SEC, which could be material to investors.
Risk Assessment
Risk Level: low — This filing is a standard procedural report and does not contain specific financial or operational risks.
Key Players & Entities
- Innate Pharma SA (company) — Registrant
- May 15, 2025 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, have filed or are required to file with a stock exchange, or have distributed or are required to distribute to their security holders.
What specific information was included in the press release dated May 15, 2025?
The filing indicates that Exhibit 99.1 is a press release dated May 15, 2025, but the content of the press release is not detailed within the provided 6-K header information.
Does Innate Pharma file annual reports on Form 20-F?
Yes, the filing indicates with a checkmark that Innate Pharma files annual reports under cover of Form 20-F.
What is Innate Pharma's principal executive office address?
Innate Pharma's principal executive office is located at 117 Avenue de Luminy—BP 30191, 13009 Marseille, France.
What is the SIC code for Innate Pharma?
The Standard Industrial Classification (SIC) code for Innate Pharma is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 15, 2025 regarding Innate Pharma SA (IPHYF).